Vimarsana
Biggest News Aggregation in the World

Page 11 - John Buse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Buse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Buse Today - Breaking & Trending Today

FDA approves a drug that can delay Type 1 Diabetes - Vimarsana News

FDA approves a drug that can delay Type 1 Diabetes

The Food and Drug Administration has approved the first treatment that can delay — possibly for years — the onset of Type 1 diabetes, a disease that often emerges in teenagers.

COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment - Vimarsana News

COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
A new generation of weight loss drugs makes bold promises, but who really wins? - Vimarsana News

A new generation of weight loss drugs makes bold promises, but who really wins?

Wegovy is one of several drugs that promise substantial weight loss. But patient experiences, along with shifting perspectives on excess weight in medicine, call into question what benefits those drugs really offer.

Source: qz.com
Drinking Wine With Dinner May Reduce the Risk for Developing Type 2 Diabetes - Vimarsana News

Drinking Wine With Dinner May Reduce the Risk for Developing Type 2 Diabetes

Study finds that the timing of alcohol consumption may influence its health benefits, but moderation is critical and risks are significant.

Stem Cell Treatment Improves Type 1 Diabetes in 1 Patient - Vimarsana News

Stem Cell Treatment Improves Type 1 Diabetes in 1 Patient

Here’s what you need to know about how this experimental treatment was developed, how it works, and its potential to improve life for people with type 1 diabetes, according to diabetes experts.